drugset / Trial / NCT00002460

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

NCT00002460

Phase 3 Unknown Cancer Research UK
Treatment

Summary

RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen. PURPOSE: Phase III trial to compare the effectiveness of adjuvant therapy using tamoxifen or ovarian ablation with goserelin or both in treating women with stage I or stage II breast cancer.

Timeline

Start
1987-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Goserelin Other / unclassified Other
Subject Tamoxifen Small molecule